CCL2 and type 2 diabetes mellitus: The concentrations of other molecules, such Monocyte Chemoattractant Protein-1 (MCP1), Lipoprotein-Associated Phospholipase A2 (LP-PLA2), and transforming growth factors (also known as tumourgrowth factor) TGF-β1, are also higher in T2D patients [15].